Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Y Ling

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Human Molecular Genetics|January 14, 2016
Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onsetZhihua Feng, Karen K Y Ling, Xin Zhao, et al.
Human Molecular Genetics|November 17, 2020
Corrigendum to: Pharmacologically-induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onsetZhihua Feng, Karen K Y Ling, Xin Zhao, et al.
EMBO Molecular Medicine|September 10, 2013
Pathological impact of SMN2 mis-splicing in adult SMA miceKentaro Sahashi, Karen K Y Ling, Yimin Hua, et al.
Journal of Neurocytology|March 23, 2004
ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctionsKarl W K Tsim, Roy C Y Choi, Nina L Siow, et al.
Human Molecular Genetics|August 9, 2021
SMN protein is required throughout life to prevent spinal muscular atrophy disease progressionXin Zhao, Zhihua Feng, Nicole Risher, et al.
Human Molecular Genetics|March 3, 2016
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophyXin Zhao, Zhihua Feng, Karen K Y Ling, et al.
Human Molecular Genetics|January 2, 2017
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron diseaseDaniel Fil, Abigail DeLoach, Shilpi Yadav, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Human Molecular Genetics|January 14, 2016
Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onsetZhihua Feng, Karen K Y Ling, Xin Zhao, et al.
Human Molecular Genetics|November 17, 2020
Corrigendum to: Pharmacologically-induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onsetZhihua Feng, Karen K Y Ling, Xin Zhao, et al.
EMBO Molecular Medicine|September 10, 2013
Pathological impact of SMN2 mis-splicing in adult SMA miceKentaro Sahashi, Karen K Y Ling, Yimin Hua, et al.
Journal of Neurocytology|March 23, 2004
ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctionsKarl W K Tsim, Roy C Y Choi, Nina L Siow, et al.
Human Molecular Genetics|August 9, 2021
SMN protein is required throughout life to prevent spinal muscular atrophy disease progressionXin Zhao, Zhihua Feng, Nicole Risher, et al.
Human Molecular Genetics|March 3, 2016
Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophyXin Zhao, Zhihua Feng, Karen K Y Ling, et al.
Human Molecular Genetics|January 2, 2017
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron diseaseDaniel Fil, Abigail DeLoach, Shilpi Yadav, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 5